PROLACTA BIOSCIENCE
Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prola... ct+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products.
PROLACTA BIOSCIENCE
Industry:
Biotechnology Health Care Life Science Nutrition
Founded:
1999-01-01
Address:
City Of Industry, California, United States
Country:
United States
Website Url:
http://www.prolacta.com
Total Employee:
51+
Status:
Active
Contact:
6265999269
Email Addresses:
[email protected]
Total Funding:
78.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
PROOF Fund
PROOF Fund investment in Venture Round - Prolacta Bioscience
Aisling Capital
Aisling Capital investment in Venture Round - Prolacta Bioscience
Health Evolution Partners
Health Evolution Partners investment in Venture Round - Prolacta Bioscience
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - Prolacta Bioscience
Health Evolution Partners
Health Evolution Partners investment in Series D - Prolacta Bioscience
PhillipCapital
PhillipCapital investment in Series C - Prolacta Bioscience
Arcturus Capital
Arcturus Capital investment in Series C - Prolacta Bioscience
Funk Ventures
Funk Ventures investment in Series C - Prolacta Bioscience
Draper Associates
Draper Associates investment in Series C - Prolacta Bioscience
DFJ Mercury
DFJ Mercury investment in Series C - Prolacta Bioscience
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-07 | Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer |
Official Site Inspections
http://www.prolacta.com Semrush global rank: 791.7 K Semrush visits lastest month: 55.03 K
- Host name: 20.98.97.233
- IP address: 20.98.97.233
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
